Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Base estimates & workings
1.5 Forecast calculations
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global intracranial aneurysm market 360° synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Treatment type trends
2.1.4 End-use trends
Chapter 3 Intracranial Aneurysm Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory scenario
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing awareness regarding intracranial aneurysms
3.5.1.2 Growing geriatric population
3.5.1.3 Increasing advances in medical technology
3.5.1.4 Rising incidence of hypertension and lifestyle-related diseases
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of treatment
3.5.2.2 Limited access to advanced care
3.6 Growth potential analysis
3.6.1 By treatment type
3.6.2 By end-use
3.7 Future market trends
3.8 Reimbursement scenario
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Intracranial Aneurysm Market Size and Forecast, By Treatment Type, 2018-2032 (USD Million)
5.1 Key trends, by treatment type
5.2 Endovascular coiling
5.3 Surgical clipping
5.4 Flow diverters
5.5 Other treatment types
Chapter 6 Intracranial Aneurysm Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Clinics
6.4 Other end-users
Chapter 7 Intracranial Aneurysm Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Israel
7.6.5 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Medtronic
8.2 Stryker
8.3 MicroPort Scientific Corporation
8.4 Johnson & Johnson Services, Inc.
8.5 MicroVention Inc.
8.6 Integra LifeSciences
8.7 B. Braun Melsungen AG
8.8 Delta Surgical
8.9 Mizuho Medical Co. Ltd.
8.10 Penumbra, Inc.
